Overview

Daily Tadalafil and Gastric Emptying Time in Diabetic Gastroparesis

Status:
Withdrawn
Trial end date:
2013-12-01
Target enrollment:
Participant gender:
Summary
The investigators hypothesize that in adult patients with diabetic gastroparesis with Type 1 diabetes (HbA1c ≤ 10.5%), daily tadalafil use will significantly improve gastric emptying compared to baseline as measured by gastric emptying time.
Phase:
Phase 4
Details
Lead Sponsor:
Mark Feinglos
Collaborators:
Duke University
Eli Lilly and Company
Treatments:
Tadalafil